Adiponectin exerts an antidiabetic function through the adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2). The mechanism regulating the expression of adiponectin receptors remains to be elucidated. Bioinformatics analysis demonstrated that microRNA (miR)-218 targets the 3' untranslated region (3'UTR) of the AdipoR2 mRNA. The present study aimed to investigate whether miR-218 regulated the expression of AdipoR2 using immunoblotting, reverse transcription quantitative polymerase chain reaction and luciferase assays. The protein level and the mRNA level of AdipoR2 were reduced when miR-218 was expressed in HepG2 cells. Additionally, overexpression of miR-218 repressed the activity of a luciferase reporter containing the 3'UTR of AdipoR2. Furthermore, the present study aimed to determine whether miR-218 regulated glucose metabolism through detecting signaling pathways and glucose uptake. The phosphorylation of AMP-activated protein kinase and p38 mitogen-activated protein kinase was reduced in miR-218-expressing cells. In addition, miR-218 inhibited adiponectin-induced glucose uptake. The present results suggested that miR-218 targets AdipoR2 to inhibit adiponectin signaling.
Introduction
Adiponectin, derived from adipocytes, is a circulating plasma protein. It has been observed to have a number of effects on metabolism, including insulin sensitization and vascular protective properties (1) . Human studies have revealed that in obese individuals plasma adiponectin levels are significantly decreased (2) , as is the case in patients with insulin resistance (3) and Type 2 diabetes (4). Insulin resistance may be induced in mice via targeted deletion of the adiponectin gene (5) , whereas increasing the expression of adiponectin resulted in a greater level of insulin sensitivity (3, 6) . Such findings have led to the hypothesis that adiponectin is an anti-inflammatory, insulin-sensitizing adipokine, which may have protective effects in metabolic diseases associated with obesity.
The adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) mediate the physiological effects of adiponectin in the liver and in the skeletal muscle, regarding the metabolism of glucose and lipids (7) . The adiponectin receptors are 7-transmembrane proteins. The signaling pathways responsible for the effects of adiponectin on metabolism remain to be fully elucidated. The adiponectin-activated AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor (PPAR)-α, and the p38 mitogen-activated protein kinase (MAPK) pathways (7) have all been revealed to involve AdipoR1 and AdipoR2, and to mediate the metabolism of glucose and lipids. However, the mechanism, which regulates the expression of the adiponectin receptors remains to be elucidated.
MicroRNAs (miRNAs) are a class of 22 nucleotide noncoding RNAs, which regulate gene expression at the post-transcriptional level. miRNAs silence their target genes by cleaving mRNA molecules or inhibiting their translation and thus regulate various physiological and pathological processes (8) . A previous study indicated that miRNAs act as key regulators in insulin signaling and glucose metabolism (9) . For example, miR-375 was observed to suppress glucose-induced insulin secretion (10) . Other miRNAs, including Let-7 (11, 12) , miR-103, miR-107 (13) and miR-29a/b (14) were revealed to regulate insulin sensitivity in the liver and peripheral tissues by controlling the expression of numerous components of the insulin signaling pathway. In the present study, it was observed that miR-218 inhibits adiponectin signaling and glucose uptake by targeting AdipoR2. Plasmid construction. The wild-type 3'-untranslated region (3'-UTR) of the AdipoR2 gene containing the predicted miR-218 target sites was amplified using polymerase chain reaction (PCR) from HepG2 cDNA using the following primer set (Sangon Biotech Co., Ltd.): AdipoR2, forward 5'-GCTCTAGATACCTACCAGTCTCCAGG-3' and reverse 5'-GCTCTAGATAGAAACTGAGAATACAGC-3'. The 3'-UTR fragment was cloned downstream of the firefly luciferase coding region in the XbaI site of the pGL3-control plasmid (Promega Corporation, Madison, WI, USA).
Materials and methods

Cell
Transfection. HepG2 cells were transiently transfected with 50 nM of the chemically synthesized miR-218, 5'-UUGUGCUUGAUCUAACCAUGU-3', or negative control miRNA, 5'-UUCUCCGAACGUGUCACGU-3' (Genepharma, Shanghai, China), using Lipofectamine 2000 (Invitrogen Life Technologies) according to the manufacturer's instructions. After 24 h transfection, cells were used for subsequent experimentation.
Dual-luciferase reporter assay. HepG2 cells were co-transfected with pGL3-AdipoR2-3'UTR together with an RNA oligonucleotide. Equal amount of renilla luciferase were co-expressed as the internal control. The cell extracts were prepared 24 h after transfection and the luciferase activity was measured using the dual-luciferase reporter assay system (Promega Corporation). The firefly luciferase activity was normalized to Renilla luciferse activity (15) .
Immunoblotting. The cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed in ice-cold lysis buffer (100 mM Tris-HCl, pH 7.5; 300 mM NaCl, 1% NP-40 and 1 mM DTT) containing protease inhibitor cocktail tablets (Cell Signaling Technology, Beverly, MA, USA).
The cell lysates were resuspended in SDS loading buffer, heated at 95˚C for 5 min and separated using SDS-PAGE. Immunocomplexes were analyzed via immunoblotting using a polyclonal goat anti-AdipoR2 antibody (sc-46751; 1:1,000; Cell Signaling Technology), followed by a polyclonal donkey anti-goat immunoglobulin G conjugated with horseradish peroxidase (sc-2020; 1:1,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Immunodetection was performed with an enhanced chemiluminescence kit (Cell Signaling Technology). Statistical analysis. The data are presented as the mean ± standard deviation. Statistical differences between groups were determined using Student's t-test. All statistical analyses were performed using Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA). P<0.01 was considered to indicate a statistically significant difference.
Results
miR-218 targets AdipoR2 mRNA.
To identify potential AdipoR2-targeting miRNAs, an in silico search was initially performed using publicly available algorithms, including TargetScan (www.targetscan.org) and miRanda (www. microrna.org). miR-218 was identified as a candidate miRNA for targeting of AdipoR2. Phylogenetic analysis revealed that miR-218 is well-conserved among different species, ranging from Canis familiaris to Homo sapiens (Fig. 1A) . A total of seven nucleotides in the 3'UTR of the human AdipoR2 mRNA are perfectly complementary to nucleotides 1-7 of miR-218 and this sequence is highly conserved in mRNA orthologs of different species (Fig. 1B) . Several approaches were subsequently employed to determine whether miR-218 regulates AdipoR2 expression. Overexpression of miR-218 mimics reduced the AdipoR2 mRNA level to ~60% that of the control group (Fig. 2A) . The AdipoR2 protein level was also significantly reduced when cells were transfected with miR-218 mimics (Fig. 2B) . Luciferase assays were then performed to further confirm the regulatory role of miR-218 in the expression of AdipoR2. The 3'UTR of the AdipoR2 gene was cloned downstream of the coding sequence of luciferase. This construct was co-transfected into HepG2 cells with miR-218 or control. The data demonstrated that miR-218 specifically decreased the luciferase levels (Fig. 2C) . These results suggested that miR-218 directly binds to the 3'UTR of AdipoR2 mRNA and reduces AdipoR2 expression.
miR-218 inhibits AMPK and p38 MAPK pathways. AdipoR2 has been revealed to be involved in the adiponectin-activated AMP-activated protein kinase and p38 mitogen-activated protein kinase pathways (7), and further mediates the effect of adiponectin on glucose metabolism. The inhibition of AdipoR2 by miR-218 prompted the hypothesis that miR-218 may affect AMPK and p38 MAPK activation. Therefore, cells were transfected with miR-218 or negative control and cells were treated with adiponectin. The data revealed that phosphorylation of p38 MAPK and AMPK decreased in miR-218 expressing cells (Fig. 3) , suggesting that miR-218 inhibited the adiponectin-activated AMPK and p38 MAPK pathways.
miR-218 inhibits adiponecin-induced glucose uptake.
Adiponectin enhances glucose uptake, therefore, it was proposed that miR-218 may regulate adiponectin-induced glucose metabolism. To assess this hypothesis, HepG2 cells transfected with miR-218 were then incubated with adiponectin and the uptake of 2-NBDG, a metabolizable fluorescent derivative of glucose, was measured. As expected, adiponectin treatment was observed to markedly increase glucose uptake by ~1.67±0.15 fold more than that of the untreated group. Adiponectin-induced glucose uptake was reduced by 0.97±0.21 fold when miR-218 was expressed (Fig. 4) , indicating that miR-218 inhibits adiponectin-induced glucose uptake.
Discussion
As adiponectin has been observed to exhibit a significant antidiabetic function, elucidating the adiponectin signaling pathway is essential to harness the therapeutic potential of this hormone. Adiponectin receptors may have important roles in adiponectin signaling transduction. However, the mechanism regulating the expression of adiponectin receptors remains to be elucidated. In the present study, it was demonstrated that miR-218 directly targets AdipoR2. In addition, it was demonstrated that miR-218 inhibits adiponectin signaling and glucose uptake by repressing AdipoR2 expression.
The expression levels of AdipoR1 and AdipoR2 are closely associated with insulin sensitivity. AdipoR1 expression was decreased in the skeletal muscle of Type 2 diabetic patients (16) . The expression of AdipoR1 and AdipoR2 in skeletal muscle and the liver is significantly increased in fasted mice and decreased in refed mice (17) . Insulin deficiency induced by streptozotocin increased the expression of AdipoR1 and AdipoR2, and insulin replenishment reduced the expression of AdipoR1 and AdipoR2 in vivo (17) . Insulin also reduced the expression of AdipoR1 and AdipoR2 in hepatocytes or myocytes via the phosphoinositide 3-kinase/ Foxo1-dependent pathway in vitro (17) . However, other studies have demonstrated that insulin may also decrease the expression of AdipoR1, but not AdipoR2 in primary cultured neonatal rat ventricular myocytes (18) and L6 myoblasts (19) . The inconsistency in the expression of AdipoRs suggested that the expression regulation of AdipoR1 and AdipoR2 is complicated and not restricted to the transcriptional level. The present data indicated that miR-218 regulates AdipoR2 expression at the posttranscriptional level, nevertheless the physiological and pathological significance of miR-218-repressed AdipoR2 expression requires further investigation.
It has been observed that miR-218 is a multifunctional microRNA. It acts as a tumor suppressor in numerous types of cancer, including oral cancer (20) , mesenchymal glioblastoma (21) and medulloblastoma (22) . miR-218 inhibits the expression of the mammalian target of rapamycin component Rictor and therefore inhibits AKT phosphorylation and cell proliferation (20) . Through targeting the receptor tyrosine kinase signaling pathway, miR-218 inhibits the activation of hypoxia-inducible factor and thereby inhibits glioblastoma multiforme cell survival and angiogenesis (21) . In addition to its tumor-suppressing effects, miR-218 was also observed to be involved in cell differentiation. Through downregulation of Wnt signaling inhibitors, miR-218 may activate Wnt signaling to promote the differentiation of osteoblasts (23) or osteogenic differentiation of human adipose tissue-derived stem cells (24) . In the present study, the role of miR-218 in glucose metabolism was revealed, for the first time to the best of our knowledge, as demonstrated by the observation that overexpression of miR-218 inhibits the AMPK and p38 MAPK pathways (Fig. 3) and adiponectin-induced glucose uptake (Fig. 4) . Further studies using mouse models may assist in elucidating the function of miR-218 in glucose metabolism and the development of diabetes.
In conclusion, AdipoR2 has been identified as a direct target of miR-218. Furthermore, miR-218 was revealed to inhibit adiponectin-induced AMPK and p38 MAPK activation and glucose uptake in HepG2 cells. These results indicated that miR-218 targets AdipoR2 to inhibit the adiponectin signaling pathway. This data may also provide a potential target for diabetes therapy through inhibiting miR-218.
